Profile Detail
ADU-CRI Research teams comprise of national and International Scientists and Clinicians that have expertise in cancer care and research.
ADU-CRI Research teams comprise of national and International Scientists and Clinicians that have expertise in cancer care and research.
Professor Rifat Hamoudi, Ph.D, C.Eng, C.Sci is a multi and inter-disciplinary researcher with deep background and work experience that spans the fields of Medicine, Engineering and Computer Science. He started out as electronic engineer but moved into medical sciences. He has three different MSc degrees from the University of London in Biochemistry & Molecular Biology, Electronic Engineering and Computer Science respectively. He has a PhD from University of Cambridge in Pathology & Immunology.
He worked in cancer genetics at the Royal Marsden Hospital and Institute of Cancer Research, United Kingdom and was a member of the team that discovered BRCA2 gene. Following the publishing of the human genome in 2001 he moved to work in molecular pathology establishing and applying novel wet methodologies, algorithms and software for molecular screening and personalised medicine, diagnostic and prognostic biomarker discoveries and understanding the molecular mechanism of various cancers with a view to identifying key diagnostic and therapeutic targets.
He is also a professor in Molecular and Computational Pathology at University College London (UCL), UK where he identified therapeutic targets using novel bioinformatics methods and used them in photo and sono-dynamic therapy to address the problems of heterogeneity and clonal evolution in of many cancers. This work led to a clinical trial using photochemical internalisation to treat various aggressive cancers, which was published in Lancet Oncology journal.
More recently he has focused on developing mathematical formulae, AI algorithms and software and applying them to gain deeper understand of the initiation and progression of various cancers. He has more than 250 publications in high impact journals including PNAS, Nature, Nature Genetics, Lancet, Science and Cell in areas spanning bioinformatics, cancer genetics and molecular pathology.